Literature DB >> 2572698

Remodeling the pyramid--a concept whose time has not yet come.

E V Hess, M E Luggen.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2572698

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

1.  In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?

Authors:  R J Rooney; W W Buchanan
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Rheumatology in the future.

Authors: 
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

Review 3.  Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

Authors:  T Pullar
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 4.  Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis.

Authors:  Roxana Coras; Rekha Narasimhan; Monica Guma
Journal:  Transl Res       Date:  2018-07-19       Impact factor: 7.012

Review 5.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

6.  Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 years.

Authors:  T Sokka; P Hannonen
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

Review 7.  Biomarkers predicting a need for intensive treatment in patients with early arthritis.

Authors:  I González-Álvaro; A M Ortiz; I V Seoane; R García-Vicuña; C Martínez; R P Gomariz
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.